Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Cassava Shares Rise on Updated Phase 2b Alzheimer's Drug Trial Data

Shares of Cassava Sciences traded 70% higher after the firm provided updates from its Phase 2b study of PTI-125 for use in treating Alzheimer' disease. Clinical-stage biotechnology company Cassava Sciences Inc. (SAVA:NASDAQ) , which focuses on neurodegenerative di...
Streetwise Reports | June 4, 2020 |

Coronavirus Propels Telemedicine into the Spotlight

Summary: Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the '90s but had failed to catch on. Now, a concerted effort by healthcare providers, insurance companies, the federal government...
Streetwise Reports | March 27, 2020 |

Gold Explorer Advancing Two Canadian Properties, Benefiting from New Brunswick Protection Status ...

Gold Explorer Advancing Two Canadian Properties, Benefiting from New Brunswick Protection Status of Mining Claims X-Terra Resources has the funding to simultaneously explore two of its properties. X-Terra Resources Inc.'s (XTT:TSX; XTR:FSE) gold...
Streetwise Reports | April 9, 2020 |

NASDAQ Listing & $100M Sales Guidance Fuels Peak’s H2/21

eResearch is pleased to publish an update Equity Research Report on Peak Fintech Group (PKK) ( CSE.PKK , OTC: PKKFF , Forum ) pertaining to the recent release of its revenue & EBITDA guidance. We are maintaining our Speculative Buy rating and increasing our one-year pr...
Featured Submission | August 3, 2021 |

Opportunity Knocks as the Door Opens to Naturally-Derived Psychedelics

(CLICK IMAGE TO PLAY VIDEO) Stockhouse investors know that investment opportunities are opening up in the burgeoning psychedelics space. And while many are called, few are chosen. One company that looks to be the choice of many in the know is Filament Health Co...
Dave Jackson | July 12, 2021 |

Crystal Lake Mining In The News

Crystal Lake Mining Corporation ( TSXV: CLM; OTC: SIOCF; FSE: SOG-FF) (”Crystal Lake” or the “ Company ”) has reported some interesting forward-motion developments lately, including the inclusion of two...
Dr. Kal Kotecha | June 20, 2019 |

Morning Market Outlook for April 5, 2024

Stephen Whiteside of TheUpTrend.com closely monitors the VIX, commodities, the TSX, market movers and a lot more in Friday’s Morning Market Outlook. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with daily updates...
TheUpTrend | April 5, 2024 |

Maiden Resource Estimate Raised as Drill Results 'Continue to Impress'

Assays and resource forecasts pertaining to this silver project in Bolivia are discussed in a ROTH Capital Partners report. In an Aug. 29 research note, Joe Reagor reported that ROTH Capital Partners increased its estimate of New Pacific Metals Corp.'s (NUAG:TSX.V; N...
Streetwise Reports | September 24, 2019 |

Biopharma Shows 'Good Start to 2020 News Flow'

The two developments that already took place this year are addressed in an H.C. Wainwright & Co. report. In a Jan. 16 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Ligand Pharmaceuticals Inc. (LGND:NASDAQ) kicked off the year with news ...
Streetwise Reports | January 22, 2020 |

Neurotrope's Shares Double on Phase 2 Alzheimer's Study Data and $2.7 Million NIH Grant

Neurotrope's shares traded higher today after reporting results from its Phase 2 "203" clinical trial of Byrostatin-1 for treatment of moderately severe to severe Alzheimer's patients. The firm has also been awarded a $2.7 million grant from the National Institutes of Health t...
Streetwise Reports | January 23, 2020 |
1 2 3 4 5 6 7 8 9 10 ...